5. STOCKHOLDERS' EQUITY (Details Narrative) - USD ($) |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Net proceeds from sale of stock | $ 33,399,000 | $ 0 |
January 2021 Offering [Member] | ||
Sale of stock, shares | 3,076,924 | |
Sale of stock, price per share | $ 2.60 | |
Net proceeds from sale of stock | $ 8,000,000 | |
Offering expenses | $ 73,000 | |
February 2021 Offering [Member] | ||
Sale of stock, shares | 2,926,830 | |
Sale of stock, price per share | $ 4.10 | |
Net proceeds from sale of stock | $ 12,000,000 | |
Offering expenses | $ 70,000 | |
March 2021 Offering [Member] | ||
Sale of stock, shares | 1,512,499 | |
Sale of stock, price per share | $ 9.00 | |
Net proceeds from sale of stock | $ 13,600,000 | |
Offering expenses | $ 72,000 |
X | ||||||||||
- Definition The cumulative amount of offering costs allocated to the general partner. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|